Published in Cancer Res on April 01, 1986
Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment. Clin Dev Immunol (2011) 1.24
Experimental approaches for the treatment of malignant gliomas. Pharmacol Ther (2010) 1.23
Immunotherapy of malignant brain tumors. Immunol Rev (2008) 1.20
Glioblastoma multiforme: State of the art and future therapeutics. Surg Neurol Int (2014) 1.18
Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol (1987) 1.07
Overview of cellular immunotherapy for patients with glioblastoma. Clin Dev Immunol (2010) 1.05
Recent developments on immunotherapy for brain cancer. Expert Opin Emerg Drugs (2012) 1.03
Toward effective immunotherapy for the treatment of malignant brain tumors. Neurotherapeutics (2009) 1.00
Immunotherapy for the treatment of glioblastoma. Cancer J (2012) 0.93
Challenges in clinical design of immunotherapy trials for malignant glioma. Neurosurg Clin N Am (2010) 0.91
Cellular immunotherapy for high-grade glioma. Immunotherapy (2011) 0.91
Cytokine networks in glioma. Neurosurg Rev (2011) 0.88
A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy. J Immunol Res (2014) 0.85
Cellular-based immunotherapies for patients with glioblastoma multiforme. Clin Dev Immunol (2012) 0.84
Vaccine strategies for glioblastoma: progress and future directions. Immunotherapy (2013) 0.81
Recent advances and future of immunotherapy for glioblastoma. Expert Opin Biol Ther (2016) 0.77
Passive immunotherapeutic strategies for the treatment of malignant gliomas. Neurosurg Clin N Am (2012) 0.75
The value of EGFRvIII as the target for glioma vaccines. Am Soc Clin Oncol Educ Book (2014) 0.75
In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes. Clin Exp Immunol (1990) 0.75
Exogenous interleukin regulates growth of C6 tumors in vivo. Acta Neuropathol (1988) 0.75
Tumor-infiltrating lymphocytes (TILs) from patients with glioma. Oncoimmunology (2016) 0.75
Immunology of gliomas. Childs Nerv Syst (1989) 0.75
History and current state of immunotherapy in glioma and brain metastasis. Ther Adv Med Oncol (2017) 0.75
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med (1982) 8.74
Detection and serotyping of herpes simplex virus in MRC-5 cells by use of centrifugation and monoclonal antibodies 16 h postinoculation. J Clin Microbiol (1985) 6.05
Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science (1984) 4.90
Ability of anaesthetists to identify a marked lumbar interspace. Anaesthesia (2000) 4.10
The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis. Mol Biol Evol (2004) 2.70
Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med (1983) 2.67
Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res (1981) 2.49
DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol (1992) 2.37
The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc Natl Acad Sci U S A (1987) 2.22
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology (1982) 1.99
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med (1983) 1.99
Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J Natl Cancer Inst (1994) 1.83
Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res (1994) 1.59
Unexpected production loss caused by helminth parasites in weaned beef calves. Vet Rec (2010) 1.53
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res (2000) 1.52
Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing. J Clin Microbiol (2014) 1.48
Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation (1993) 1.45
Increased platelet responsiveness following coronary stenting. Heparin as a possible aetiological factor in stent thrombosis. Eur Heart J (1998) 1.43
Solubilities of hydrophobic compounds in aqueous-organic solvent mixtures. Environ Monit Assess (1987) 1.43
Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins. Cancer Res (1982) 1.41
Verbal communication of ventilator-dependent patients. Crit Care Med (1993) 1.39
Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect Immun (1993) 1.36
Evaluation and treatment of the upper extremity in the hemiplegic stroke patient. Clin Orthop Relat Res (1969) 1.35
Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci (1994) 1.34
Real-time ultrasound elastography of the normal Achilles tendon: reproducibility and pattern description. Clin Radiol (2009) 1.33
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology (1982) 1.31
Ultrasound elastography for musculoskeletal applications. Br J Radiol (2012) 1.29
Molecular and spatial epidemiology of human campylobacteriosis: source association and genotype-related risk factors. Epidemiol Infect (2010) 1.29
Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate. J Immunol (1979) 1.29
Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens. J Immunol (1981) 1.29
Histopathologic study of the effect of retinal detachment surgery on 49 eyes obtained post mortem. Am J Ophthalmol (1987) 1.28
Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg (1985) 1.27
Choroidal neovascularization. Ophthalmology (1986) 1.27
Mycoplasma bovis infections in cattle. J Vet Intern Med (2011) 1.25
Radiation-induced cancer: a modern view. Br J Radiol (2012) 1.24
Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection. Genetics (2006) 1.20
Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int J Cancer (2001) 1.19
Functional test for the hemiparetic upper extremity. Am J Occup Ther (1984) 1.17
Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res (1998) 1.16
Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. J Clin Oncol (1997) 1.15
Immunolocalization of integrins in the human retina. Invest Ophthalmol Vis Sci (1994) 1.15
Regulation of lymphocyte tumor necrosis factor receptors by IL-2. J Immunol (1989) 1.15
Ingestion of formic acid-containing agents--report of three fatal cases. Postgrad Med J (1980) 1.14
S-100 protein in human acoustic neurinomas. Brain Res (1972) 1.14
MRI and clinical study of an easy and safe technique of suprascapular nerve blockade. Acta Anaesthesiol Belg (1994) 1.11
Radiation sensitivity of cultured human glioblastoma cells. Radiology (1977) 1.10
Effect of pathogen-specific clinical mastitis on milk yield in dairy cows. J Dairy Sci (2004) 1.10
An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest Ophthalmol Vis Sci (1996) 1.09
Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells. Cancer Res (1989) 1.09
Can MRI of the knee affect arthroscopic practice? A prospective study of 58 patients. J Bone Joint Surg Br (1993) 1.08
Biochemically differentiated clonal human glial cells in tissue culture. J Neurobiol (1970) 1.07
Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol (1997) 1.04
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Transplantation (1993) 1.03
Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum, and striatum. Glia (1992) 1.03
In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogeneic cultured gliomas. J Natl Cancer Inst (1982) 1.02
Temporal patterns of lost milk production following clinical mastitis in a large Michigan Holstein herd. J Dairy Sci (1991) 1.02
Arthrosonography of the painful hip. Clin Radiol (1984) 1.02
Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch Otolaryngol Head Neck Surg (1994) 1.01
The role of magnetic resonance imaging in the management of peripheral nerve tumours. J Hand Surg Br (1997) 1.01
Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer (2001) 1.01
Efficacy of strength training in prepubescent to early postpubescent males and females: effects of gender and maturity. Pediatr Rehabil (1998) 1.01
Response of cultured human brain tumors to nitrosoureas: correlation with clinical data. Cancer (1981) 1.00
Advances in computational studies of energy materials. Philos Trans A Math Phys Eng Sci (2010) 1.00
Multiple intestinal 'loops' provide an in vivo model to analyse multiple mucosal immune responses. J Immunol Methods (2001) 1.00
Characterization of the M(r) 65,000 lymphokine-activated killer proteins phosphorylated after tumor target binding: evidence that pp65a and pp65b are phosphorylated forms of L-plastin. Cancer Res (1996) 1.00
Observations on the emergence of multiple anthelmintic resistance in sheep flocks in the south-east of Scotland. Vet Parasitol (2006) 0.99
Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas. Clin Exp Immunol (1996) 0.99
Experimental glioma in primates: a computed tomography model. J Comput Assist Tomogr (1980) 0.99
Cavity opto-mechanics using an optically levitated nanosphere. Proc Natl Acad Sci U S A (2009) 0.99
Identification of a cyclohexylcarbonyl CoA biosynthetic gene cluster and application in the production of doramectin. Nat Biotechnol (2000) 0.99
Characterization of human copine III as a phosphoprotein with associated kinase activity. Biochemistry (2000) 0.98
Immunolocalization of integrins in proliferative retinal membranes. Invest Ophthalmol Vis Sci (1994) 0.98
Cleanup of fractured rock aquifers: Implications of matrix diffusion. Environ Monit Assess (1993) 0.98
Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc (1994) 0.97
Evaluation of mild lameness in horses trotting on a treadmill by clinicians and interns or residents and correlation of their assessments with kinematic gait analysis. Am J Vet Res (1998) 0.97
A spot test for detection of lead in paint. Pediatrics (1970) 0.97
Mechanism of cell-mediated cytotoxicity at the single cell level. VIII. Kinetics of lysis of target cells bound by more than one cytotoxic T lymphocyte. J Immunol (1984) 0.96
A human ganglioglioma containing paired helical filaments. Hum Pathol (1984) 0.96
Fibrin scaffold as an effective vehicle for the delivery of acidic fibroblast growth factor (FGF-1). J Biomater Appl (2000) 0.95
Diversity of Streptococcus agalactiae and Staphylococcus aureus ribotypes recovered from New York dairy herds. Am J Vet Res (1997) 0.95
Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors. AJNR Am J Neuroradiol (1983) 0.95
Detection of chlamydial cervicitis by Papanicolaou stained smears and culture. Am J Clin Pathol (1983) 0.95
Determination of nicotine concentrations in human milk. Am J Dis Child (1976) 0.94
Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization. Cancer Immunol Immunother (1983) 0.94
Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res (1990) 0.94
Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells. Cancer (1984) 0.94
The effect of hypoxia and low pH on the cytotoxicity of chlorambucil. Int J Radiat Oncol Biol Phys (1992) 0.93
Artificial airways: a survey of cuff management practices. Heart Lung (1996) 0.93
Combination intravitreal rituximab and methotrexate for massive subretinal lymphoma. Eye (Lond) (2010) 0.93
Characteristics of human optic gliomas in tissue culture. J Neurosurg (1977) 0.93
Anterolateral ankle impingement: findings and diagnostic accuracy with ultrasound imaging. Skeletal Radiol (2007) 0.93
Epithelial ingrowth and apparent filtering bleb encapsulation. Am J Ophthalmol (1994) 0.92
Malignant pheochromocytoma masquerading as acute pancreatitis--a rare but potentially lethal occurrence. Mayo Clin Proc (1994) 0.92